Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
10.941
Zitationen
13
Autoren
2021
Jahr
Abstract
The fifth edition of the WHO Classification of Tumors of the Central Nervous System (CNS), published in 2021, is the sixth version of the international standard for the classification of brain and spinal cord tumors. Building on the 2016 updated fourth edition and the work of the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy, the 2021 fifth edition introduces major changes that advance the role of molecular diagnostics in CNS tumor classification. At the same time, it remains wedded to other established approaches to tumor diagnosis such as histology and immunohistochemistry. In doing so, the fifth edition establishes some different approaches to both CNS tumor nomenclature and grading and it emphasizes the importance of integrated diagnoses and layered reports. New tumor types and subtypes are introduced, some based on novel diagnostic technologies such as DNA methylome profiling. The present review summarizes the major general changes in the 2021 fifth edition classification and the specific changes in each taxonomic category. It is hoped that this summary provides an overview to facilitate more in-depth exploration of the entire fifth edition of the WHO Classification of Tumors of the Central Nervous System.
Ähnliche Arbeiten
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 · 21.168 Zit.
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
2016 · 15.678 Zit.
The 2007 WHO Classification of Tumours of the Central Nervous System
2007 · 13.880 Zit.
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 · 12.079 Zit.
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 · 7.705 Zit.
Autoren
Institutionen
- Massachusetts General Hospital(US)
- Harvard University(US)
- University of California, San Francisco(US)
- Amsterdam University Medical Centers(NL)
- Princess Máxima Center(NL)
- Northwestern University(US)
- Centre international de recherche sur le cancer(FR)
- Institut de Neurophysiopathologie(FR)
- Aix-Marseille Université(FR)
- Hôpital de la Timone(FR)
- Centre National de la Recherche Scientifique(FR)
- University of Toronto(CA)
- Hospital for Sick Children(CA)
- SickKids Foundation(CA)
- Chinese University of Hong Kong(HK)
- National Center for Tumor Diseases(DE)
- University Hospital Heidelberg(DE)
- Heidelberg University(DE)
- German Cancer Research Center(DE)
- Düsseldorf University Hospital(DE)
- Heinrich Heine University Düsseldorf(DE)
- University of Turin(IT)
- Deutschen Konsortium für Translationale Krebsforschung(DE)
- St. Jude Children's Research Hospital(US)